Drug discovery crystal ball gazing for the year ahead. And the hottest new prospects are discussed below. We have 1 CDER (FDA) approval this year, an interesting start – Zelsuvmi (berdazimer), a nitric oxide (NO) releasing agent for the treatment of molluscum contagiosum. Berdazimer is a polymeric ...